secwatch.observer — SEC 8-K summary
======================================

Issuer:     AMEDISYS INC (—)
CIK:        0000896262
Form:       8-K
Filed at:   2024-04-24T23:59:59+00:00
Accession:  0000896262-24-000018
Event type: earnings
Sentiment:  neutral
Materiality: 0.55
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Amedisys Q1 revenue up to $571.4M; adjusted EPS $1.03 vs $1.00 YoY
------------------------------------------------------------------

- Net service revenue $571.4M, up $15.0M YoY; prior year included $15M from divested personal care.
- GAAP net income $14.4M ($0.44 diluted EPS) vs $25.2M ($0.77) in 2023; includes $20.7M merger expenses.
- Adjusted EBITDA $59.9M vs $57.8M; adjusted net income $33.9M ($1.03 diluted EPS) vs $32.7M ($1.00).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/896262/000089626224000018/0000896262-24-000018-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/896262/000089626224000018/amed-20240424.htm
  HTML page:      https://secwatch.observer/filing/0000896262-24-000018

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer